Logo
Login
$DSGN
$10.63 +$0.29 (2.8%) Close

Company Executives

$DSGN Management Team

Dr. Pratik Shah

Chairman of the Board

President

Chief Executive Officer

Principal Financial Officer

Age 55
Compensation $789.8K USD
Sex Male

Dr. Sean Jeffries

Chief Operating Officer

Age 45
Compensation $1.315M USD
Sex Male

Dr. Christopher Storgard

Chief Medical Officer

Age 59
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 23, 2026
Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
4.9 years
from year joined
CEO also chairs the board
Yes
Pratik Shah
Director Age On board Independent Committees Other public boards 2025 pay Source
Simeon George
Lead independent director
 49 2020
6 years
 Independent None stated CRISPR Therapeutics AG $136,672
Pratik Shah
Board chair, CEO
 56 2017
9 years
 Not independent None stated ARS Pharmaceuticals, Inc. Paid as CEO
Justin Gover
55 2025
1 year
 Independent
Audit Committee
Compass Pathways plc $223,779
David Shapiro
71 2026
0 years
 Independent None stated Precision Biosciences, Inc. Not stated
Heather Berger
51 2021
5 years
 Independent
Audit Committee
None stated Not stated
Rodney Lappe
71 2019
7 years
 Independent None stated None stated Not stated
John Schmid
63 2020
6 years
 Independent None stated AnaptysBio, Inc. $120,714

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

4 disclosed in the proxy filed Apr 23, 2026
Pratik Shah, Ph.D.
Chief Executive Officer and Chairperson of the Board of Directors; executive officer of Marlinspike
Monthly fee of $20,000

Consulting agreement with Marlinspike Group, LLC for management and business consulting and business development support on an as-available basis

With Marlinspike Group, LLC Open in proxy
Crossing Holdings, LLC
Pratik Shah, Ph.D. and entities that he controls are the sole members of Crossing Holdings
Amount not stated
2021

Lease of approximately 12,370 square feet of laboratory and office space

With Crossing Holdings, LLC Open in proxy
Crossing Holdings, LLC
Pratik Shah, Ph.D. and entities that he controls are the sole members of Crossing Holdings
Amount not stated
2022

First amendment to the lease adding approximately 4,900 square feet of office space in the same building

With Crossing Holdings, LLC Open in proxy
Crossing Holdings, LLC
Pratik Shah, Ph.D. and entities that he controls are the sole members of Crossing Holdings
Amount not stated
January 2026

Second lease amendment extending the lease term through December 2029 and reducing base rent

Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans